News

  • Narcolepsy is a risk factor for cardiovascular disease and adverse cardiac events

    Two new studies to be presented at the SLEEP 2024 annual meeting show that narcolepsy is an independent risk factor for cardiovascular disease and adverse cardiac events. Results show that people who have narcolepsy, compared with those without narcolepsy, had a 77% increased risk of any cardiovascular disease and an 82% increased risk of major [...]

  • Huntington’s Disease Awareness Month: Insights from the expert

    Huntington’s disease (HD) is a progressive neurological condition with no known cure. The disease gradually changes an individual’s ability to walk, talk, think and communicate. NR Times called up Dr Vincent Harding, forensic and clinical psychologist at St Andrew’s Healthcare, to learn more about HD and the innovative new approaches helping patients to live well, [...]

  • Developing light-activated drugs that induce sleep

    A research team has been successful in artificially inducing sleep without genetic modification for the first time by developing a novel, light-sensitive drug. The nucleus accumbens plays a pivotal role in motivational behaviour and sleep regulation, modulated by adenosine A2A receptors (A2AR). Selective A2AR regulation within this brain region could control sleep and motivation. However, [...]

  • Powerful combination: Technology and traditional therapy approaches

    Thor Assistive Technologies recently installed two EGZOTech devices at Complete Neuro Rehab’s facility in the West Midlands. NR Times reports on the impact of the tech on patient outcomes and how it is enabling physiotherapists to “do what they do best”. “This relationship between technology and traditional physiotherapy principles works very well,” says Dave Swinburne, [...]

  • Cerebral Palsy support: Shining a light on the life-saving charities

    Cerebral Palsy affects movement and co-ordination abilities and its lifelong impact can have profound effects on whole families.  In the UK, it is estimated that one in 400 babies will have a type of Cerebral Palsy, illustrating its prevalence in society and how great the need is for support to be delivered.  Charities play a [...]

  • NR Headlines: Friday 17th May

    Welcome to your daily round-up of everything happening in the world of neurorehab.

  • FutureNeuro secures €17.9M investment to transform brain disease research

    FutureNeuro, the Science Foundation Ireland (SFI) Research Centre for Neurological Diseases, has announced an ambitious expansion of its research programme dedicated to accelerating the fight against brain diseases.

  • Watch: Achieving person-centred care in Huntington’s

    There are around 7,000 people living with Huntington's disease in the UK alone. The condition gradually reduces a person's ability to walk, talk, think and communicate, significantly impacting not only their lives but their families' and loved ones', too. In an exclusive NR Times webinar, five expert panellists addressed the current state of Huntington's disease [...]

  • Entrepreneur with MND enables disabled people to experience boating on the sea

    Having been diagnosed with Motor Neuron Disease on the day he sold his business, entrepreneur James Ashton has refused to let the progressive disease and its cruel consequences take away his long-standing love of the ocean - and is now enabling it for others too An organic food entrepreneur who says being able to continue [...]